Clinical Trial Update: Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months [Phase 3]

View source ↗

Summary

Phase 3 safety study of levocetirizine dihydrochloride oral liquid in children aged 6 to 11 months has completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• Levocetirizine dihydrochloride oral solution (levocetirizine dihydrochloride)

Snippet

Sponsor: UCB Pharma | Conditions: Allergic Rhinitis, Chronic Urticaria | Phase 3 | Status: COMPLETED | Results posted: 2009-10-14